Curative Biotechnology (CTYX) Stock Chart & Stock Price History $0.0099 +0.00 (+11.21%) As of 08/21/2025 Add Compare Share Share Chart Stock AnalysisChartBuy This Stock Curative Biotechnology Stock Price Performance The Curative Biotechnology (CTYX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 31.11%, with a year-to-date return of -26.52%. In the past month, the stock has increased 2.69%, reflecting recent market activity. As of the latest close, Curative Biotechnology traded at $0.01 with a market cap of $3.34 million and volume of 93,500 shares. Receive CTYX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Curative Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.33%1 Month Performance+2.69%3 Month Performance-30.73%Year-To-Date Performance-26.52%1 Year PerformanceN/A CTYX Stock Chart for Friday, August, 22, 2025 CTYX Chart by TradingView Curative Biotechnology Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$0.01$0.01+15.35%$0.01$0.0110,100 shs$3.85 million08/21/2025$0.01$0.01$0.01$0.0193,500 shs$3.34 million08/20/2025$0.01$0.01-13.65%$0.01$0.0193,500 shs$3.34 million08/19/2025$0.01$0.01-2.35%$0.01$0.0121,247 shs$3.87 million08/18/2025$0.01$0.01$0.01$0.0113,300 shs$3.96 million08/15/2025$0.01$0.01$0.01$0.01333,100 shs$3.73 million08/14/2025$0.01$0.01$0.01$0.01333,100 shs$3.73 million08/13/2025$0.01$0.01$0.01$0.01333,100 shs$3.73 million08/12/2025$0.01$0.01$0.01$0.01333,100 shs$3.73 million08/11/2025$0.01$0.01$0.01$0.01333,100 shs$3.73 million Get the Latest News and Ratings for CTYX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Curative Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025$0.01$0.01$0.01$0.0112,000 shs$3.61 million08/07/2025$0.01$0.01$0.01$0.0112,000 shs$3.61 million08/06/2025$0.01$0.01$0.01$0.0112,000 shs$3.61 million08/05/2025$0.01$0.01$0.01$0.0112,000 shs$3.61 million08/04/2025$0.01$0.01$0.01$0.0112,000 shs$3.61 million08/01/2025$0.01$0.01$0.01$0.0146,694 shs$3.85 million07/31/2025$0.01$0.01$0.01$0.0146,694 shs$3.85 million07/30/2025$0.01$0.01$0.01$0.0146,694 shs$3.85 million07/29/2025$0.01$0.01$0.01$0.0146,694 shs$3.85 million07/28/2025$0.01$0.01$0.01$0.0146,694 shs$3.85 million07/25/2025$0.01$0.01$0.01$0.0120,100 shs$3.75 million07/24/2025$0.01$0.01$0.01$0.0120,100 shs$3.75 million07/23/2025$0.01$0.01$0.01$0.0120,100 shs$3.75 million07/22/2025$0.01$0.01-4.92%$0.01$0.0120,100 shs$3.75 million07/21/2025$0.01$0.01$0.01$0.01319,600 shs$3.95 million Related Companies NEUP Stock Chart CTXR Stock Chart CHHE Stock Chart ALVR Stock Chart TXMD Stock Chart IBIO Stock Chart ALLR Stock Chart GELS Stock Chart IMUC Stock Chart BFRG Stock Chart Receive CTYX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Curative Biotechnology and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:CTYX) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Curative Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Curative Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access